• Applied Workflows Using O-propargyl-puromycin (OPP) in Prote

  2026-05-09

  O-propargyl-puromycin (OPP) revolutionizes protein synthesis measurement in live cells, with unmatched sensitivity and compatibility for advanced proteomics research. This guide translates recent immunology breakthroughs into actionable protocols and troubleshooting strategies for OPP-based assays.

• Diphenyleneiodonium Chloride: Precision Redox and cAMP Probe

  2026-05-08

  Diphenyleneiodonium chloride (DPI) stands out as a dual-function research tool, offering unparalleled specificity in inhibiting redox enzymes and modulating cAMP signaling. Here, we detail experimental workflows, troubleshooting tactics, and advanced applications that leverage DPI’s unique profile, informed by cutting-edge redox biology research and vendor-backed insights.

• Ether Lipid Biosynthesis in B Cells Enhances Antibody Respon

  2026-05-08

  This study establishes that B cell-intrinsic ether lipid biosynthesis, mediated by the enzyme PexRAP, is crucial for optimal antibody production and germinal center development. Using inducible gene knockout and imaging mass spectrometry in mouse models, the authors uncover a metabolic mechanism that directly supports humoral immunity, with implications for immunological research and experimental design.

• EZ Cap EGFP mRNA 5-moUTP: Enhanced Reporter for mRNA Deliver

  2026-05-07

  EZ Cap EGFP mRNA 5-moUTP is a synthetic, capped mRNA reagent optimized for high-fidelity expression of enhanced green fluorescent protein. Its Cap 1 structure and 5-methoxyuridine modification minimize immune activation and increase translation efficiency. This product enables robust, reproducible mRNA delivery and gene expression studies for research and assay development.

• EdU Imaging Kits (Cy3): Precision S-Phase Measurement in 3D

  2026-05-07

  Explore the advanced use of EdU Imaging Kits (Cy3) for precise 5-ethynyl-2'-deoxyuridine imaging of cell proliferation in complex 3D tumor organoid systems. This article uniquely reveals how integrating these assays with cutting-edge co-culture models transforms cancer research and drug response analysis.

• EdU Imaging Kits (Cy3): Precision Cell Proliferation Detecti

  2026-05-06

  EdU Imaging Kits (Cy3) revolutionize cell proliferation assays by combining click chemistry with Cy3 fluorescence for highly sensitive, denaturation-free S-phase DNA synthesis measurement. Discover how streamlined protocols and robust troubleshooting deliver reproducible results in both developmental biology and genotoxicity testing.

• Optimizing mRNA Delivery with EZ Cap™ Cy5 EGFP mRNA (5-moUTP

  2026-05-06

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) delivers precise, dual-fluorescence tracking for quantitative mRNA delivery and translation efficiency assays. Its Cap 1 structure and 5-methoxyuridine modifications set a new standard for immune-evasive, high-resolution gene regulation studies.

• Morning Training Enhances Endurance Adaptation in Mice

  2026-05-05

  Hesketh et al. (2026) demonstrate that endurance training during the early active phase (morning) in mice yields greater improvements in performance and muscle adaptation compared to afternoon training, despite lower training volumes. These findings highlight the impact of exercise timing on physiological adaptation, informing future experimental designs in circadian and metabolic research.

• Catalpol: Mechanistic Leverage for Translational Discovery

  2026-05-05

  This thought-leadership article empowers translational researchers by integrating cutting-edge mechanistic insights, validated protocols, and strategic guidance for deploying Catalpol—a multi-target iridoid glycoside—in complex disease modeling. Drawing from peer-reviewed evidence, comparative resources, and APExBIO’s high-purity standards, we provide a roadmap for advancing neuroprotection, osteoporosis, ischemic stroke, and liver fibrosis research.

• RWJ 67657: Precision p38α/β Modulation and Assay Decision-Ma

  2026-05-04

  Explore how RWJ 67657 (JNJ-3026582) enables targeted, selective p38 MAP kinase modulation for inflammatory disease research. This article uniquely translates recent structural insights into practical assay and workflow guidance for preclinical innovation.

• PERK–JAK1–STAT3 Axis Drives ER Stress-Induced Pyroptosis in

  2026-05-04

  This study reveals that excessive endoplasmic reticulum stress promotes pyroptotic cell death in nucleus pulposus cells through PERK-dependent activation of the JAK1–STAT3 pathway. These findings clarify molecular links in intervertebral disc degeneration and suggest new therapeutic targets for modulating inflammation and cell loss.

• Taltirelin Acetate in Itch and Neuroprotection: Mechanisms a

  2026-05-03

  Explore the multifaceted actions of Taltirelin acetate in acute and chronic itch, neuroprotection, and dopamine transporter modulation. This article delivers advanced protocols, mechanistic clarity, and practical insights for preclinical research, distinct from prior reviews.

• Plerixafor (AMD3100): Precision CXCR4 Inhibition for Tumor a

  2026-05-02

  Explore the scientific underpinnings of Plerixafor (AMD3100) as a CXCR4 inhibitor, with in-depth analysis of its role in cancer metastasis inhibition and hematopoietic stem cell mobilization. This article uniquely bridges molecular insights with practical assay guidance for advanced biomedical research.

• Protein A/G Magnetic Co-IP/IP Kit: Precision in Protein Comp

  2026-05-02

  The Protein A/G Magnetic Co-IP/IP Kit empowers researchers to dissect protein-protein interactions with unparalleled specificity and reproducibility. Leveraging recombinant Protein A/G magnetic beads, this kit streamlines co-immunoprecipitation workflows and accelerates discoveries in cellular signaling and ubiquitination dynamics.

• Lopinavir Identified as a Potent MERS-CoV Inhibitor in Cell

  2026-05-01

  de Wilde et al. systematically screened an FDA-approved drug library for compounds inhibiting MERS-CoV replication, identifying Lopinavir (ABT-378) among four promising small molecules. Their findings highlight the potential for repurposing established antivirals in emerging coronavirus outbreaks and offer a framework for rapid translational research.

16255 records 1/1084 page Next 12345 下5页 Last page